 |
(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate |
|---|---|
| Trade Name | |
| Orphan Indication | Soft tissue sarcoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-08-31 00:00:00 |
| Sponsor | Loxo Oncology, Inc.;One Landmark Square, Suite 1122;Stamford, Connecticut, 06901 |
